{"id":904170,"date":"2025-11-03T10:03:15","date_gmt":"2025-11-03T15:03:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/"},"modified":"2025-11-03T10:03:15","modified_gmt":"2025-11-03T15:03:15","slug":"manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/","title":{"rendered":"Manulife Becomes First Canadian Insurer to Offer the Galleri\u00ae Multi-Cancer Early Detection Test by GRAIL"},"content":{"rendered":"
\n

Canada NewsWire<\/p>\n<\/p><\/div>\n

\n

\u00a0Manulife helping Canadians take proactive steps for their health through access to innovative technology<\/i><\/p>\n

\n
\n TORONTO<\/span>
\n <\/span>, Nov. 3, 2025<\/span><\/span> \/CNW\/ – Manulife Canada today announced it is the first insurance company in Canada<\/span> to offer access to GRAIL’s\u00a0Galleri\u00ae<\/sup> multi-cancer early detection test, to eligible life insurance customers, through its innovative Manulife Vitality <\/i>program.<\/p>\n

Manulife has partnered with Medcan<\/a>,\u00a0a global leader in proactive health and wellness services and the official Canadian provider of GRAIL’s\u00a0Galleri test. Through this collaboration, eligible Manulife customers will be able to access the test at Medcan’s Toronto<\/span> and Oakville<\/span> clinics with support from Medcan’s clinical team throughout the testing process \u2013 including pre-test counselling, results review, and next-step coordination. \u00a0<\/p>\n

This milestone advances Manulife’s commitment to helping Canadians live longer, healthier, better lives by expanding access to emerging medical technologies. It also builds on the company’s broader collaboration with GRAIL and continues to support the availability of innovative early cancer detection technologies.<\/p>\n

“Manulife is proud to be at the forefront of innovation in Canadian insurance. By offering the Galleri test to eligible customers, we’re expanding access to cutting-edge health solutions that can potentially improve outcomes through early detection,” said Naveed Irshad<\/span>, President and CEO, Manulife Canada. “Cancer has touched nearly every Canadian in some way. By offering this innovative screening tool, we’re giving Canadians a stronger start in the fight \u2014 one rooted in early detection and proactive care.”<\/p>\n

“We’re proud to collaborate with Manulife to introduce this groundbreaking screening test to their customers,” said Shaun Francis<\/span>, Chair and CEO of Medcan. “At Medcan, we offer best-in-class care supported by clinically validated innovations that pave the way for a healthier future. Being the first official provider to bring GRAIL’s\u00a0Galleri test to Canada<\/span> directly aligns with our mission to empower individuals to take control of their health so they can live well, for life.”<\/p>\n

Cancer remains the leading cause of death in Canada<\/span>, with two in five Canadians expected to be diagnosed with the disease over their lifetime. Early detection is critical \u2013 the five-year survival for the most commonly diagnosed cancers exceeds 90 per cent when caught at stage one.[i]\u00a0Despite advances in treatment, many cancers are still diagnosed at later stages, when options are more limited, and survival rates drop significantly.<\/p>\n

Through a single blood draw, the Galleri test can detect more than\u00a050 types of cancer\u00a0before symptoms appear. With\u00a0a clinical program involving more than 385,000 participants, the Galleri test is among the most rigorously studied multi-cancer early detection\u00a0tests. In October, GRAIL released the initial findings<\/a>\u00a0of PATHFINDER 2 \u2013 which also includes Canada’s<\/span> largest academic hospital network, University Health Network (UHN). The results showed that adding the Galleri test to recommended\u00a0screenings\u00a0for breast, cervical, colorectal and lung cancers\u00a0increased cancer detection more than sevenfold.<\/p>\n

These benefits build on the foundation provided by Canada’s<\/span> universal public healthcare system, which offers access to essential services, including well-established screening programs for several common cancers such as breast, cervical, colorectal, and lung. These programs play a vital role in early detection and improving outcomes for Canadians.<\/p>\n

“This initiative is about looking ahead \u2013 exploring how we can responsibly expand access to promising technologies that have the potential to complement Canada’s<\/span> existing screening programs and support earlier detection,” said Paul Savage<\/span>, Head of Individual Insurance, Manulife Canada. “We’re focused on how this offering can inform future solutions that empower Canadians to take proactive steps for their health.”<\/p>\n

The Galleri test will be offered at a reduced cost through the Manulife Vitality Plus<\/i><\/a>\u00a0program and is available to eligible members aged 50+.\u00a0The industry-leading Manulife Vitality <\/i>program is available across life insurance policies, pairing long-term financial protection with a health and wellness platform that rewards healthier choices linked to physical activity, nutrition, mindfulness and more.<\/p>\n

This initiative also reflects Manulife’s global efforts to explore innovative health solutions. The company’s collaboration with GRAIL began in 2022 through its U.S. unit, John Hancock<\/span><\/a>, where the Galleri test is available to eligible life insurance\u00a0customers and retirement plan participants. The Canadian initiative builds on this foundation, marking an important step in expanding access to services that help customers better understand and make more informed choices about their health.<\/p>\n

This collaboration marks an important step in expanding access to innovative health technologies for Manulife customers. To learn more about Manulife Vitality<\/i>, visit Manulife.ca\/Vitality<\/a>.\u00a0<\/p>\n

\n About Manulife<\/b>\u00a0\u00a0<\/p>\n

Manulife Financial Corporation is a leading international financial services provider, helping people make their decisions easier and lives better. With our global headquarters in Toronto, Canada<\/span>, we provide financial advice and insurance, operating as Manulife across Canada<\/span>, Asia<\/span>, and Europe<\/span>, and primarily as John Hancock<\/span> in the United States<\/span>. Through Manulife Investment Management, the global brand for our Global Wealth and Asset Management segment, we serve individuals, institutions, and retirement plan members worldwide. At the end of 2023, we had more than 38,000 employees, over 98,000 agents, and thousands of distribution partners, serving over 35 million customers. We trade as ‘MFC’ on the Toronto<\/span>, New York<\/span>, and the Philippine stock exchanges, and under ‘945’ in Hong Kong<\/span>.<\/p>\n

Not all offerings are available in all jurisdictions. For additional information, please visit manulife.com.<\/p>\n

\n About Medcan<\/b>\n <\/p>\n

Medcan is a global leader in proactive health and wellness services and is devoted to providing care for individuals, families and employers that is grounded in the latest evidence-based practices, technologies and treatments. Our team of medical experts unites to provide transformational specialty and primary care to achieve more for you and your health.<\/p>\n

Located in downtown Toronto<\/span> (150 York St.), Oakville<\/span> (2275 Upper Middle Rd.), Collingwood<\/span> (40 Huron St.), and Muskoka (seasonal \u2013 84 Joseph St.) Medcan is here to give you more control over your health and to help you live well, for life.\u00a0Learn more at medcan.com.<\/p>\n

\n Media Contacts:<\/b>\n <\/p>\n

\n Manulife
<\/b>
\n Laura Crochetiere<\/span>
\n
Manulife Canada
Laura_Crochetiere@manulife.com<\/a>\u00a0\u00a0<\/p>\n

\n\n\n\n
\n

\n ___________________________<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n i\u00a0Statistics Canada.<\/a>\u00a0Five-year cancer survival by stage at diagnosis in Canada<\/i>. Health Reports, January 18, 2023.<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

Galleri is a registered trademark of Grail, Inc.<\/p>\n

SOURCE Manulife Financial Corporation<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Canada NewsWire \u00a0Manulife helping Canadians take proactive steps for their health through access to innovative technology TORONTO , Nov. 3, 2025 \/CNW\/ – Manulife Canada today announced it is the first insurance company in Canada to offer access to GRAIL’s\u00a0Galleri\u00ae multi-cancer early detection test, to eligible life insurance customers, through its innovative Manulife Vitality program. Manulife has partnered with Medcan,\u00a0a global leader in proactive health and wellness services and the official Canadian provider of GRAIL’s\u00a0Galleri test. Through this collaboration, eligible Manulife customers will be able to access the test at Medcan’s Toronto and Oakville clinics with support from Medcan’s clinical team throughout the testing process \u2013 including pre-test counselling, results review, and next-step coordination. \u00a0 This milestone advances Manulife’s commitment … <\/p>\n

Continue reading “Manulife Becomes First Canadian Insurer to Offer the Galleri\u00ae Multi-Cancer Early Detection Test by GRAIL”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-904170","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nManulife Becomes First Canadian Insurer to Offer the Galleri\u00ae Multi-Cancer Early Detection Test by GRAIL - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Manulife Becomes First Canadian Insurer to Offer the Galleri\u00ae Multi-Cancer Early Detection Test by GRAIL - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Canada NewsWire \u00a0Manulife helping Canadians take proactive steps for their health through access to innovative technology TORONTO , Nov. 3, 2025 \/CNW\/ – Manulife Canada today announced it is the first insurance company in Canada to offer access to GRAIL’s\u00a0Galleri\u00ae multi-cancer early detection test, to eligible life insurance customers, through its innovative Manulife Vitality program. Manulife has partnered with Medcan,\u00a0a global leader in proactive health and wellness services and the official Canadian provider of GRAIL’s\u00a0Galleri test. Through this collaboration, eligible Manulife customers will be able to access the test at Medcan’s Toronto and Oakville clinics with support from Medcan’s clinical team throughout the testing process \u2013 including pre-test counselling, results review, and next-step coordination. \u00a0 This milestone advances Manulife’s commitment … Continue reading "Manulife Becomes First Canadian Insurer to Offer the Galleri\u00ae Multi-Cancer Early Detection Test by GRAIL"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T15:03:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C0702&Transmission_Id=202511030800CANADANWWEB______C0702&DateId=20251103\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Manulife Becomes First Canadian Insurer to Offer the Galleri\u00ae Multi-Cancer Early Detection Test by GRAIL\",\"datePublished\":\"2025-11-03T15:03:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\\\/\"},\"wordCount\":999,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/rt.prnewswire.com\\\/rt.gif?NewsItemId=C0702&Transmission_Id=202511030800CANADANWWEB______C0702&DateId=20251103\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\\\/\",\"name\":\"Manulife Becomes First Canadian Insurer to Offer the Galleri\u00ae Multi-Cancer Early Detection Test by GRAIL - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/rt.prnewswire.com\\\/rt.gif?NewsItemId=C0702&Transmission_Id=202511030800CANADANWWEB______C0702&DateId=20251103\",\"datePublished\":\"2025-11-03T15:03:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\\\/#primaryimage\",\"url\":\"https:\\\/\\\/rt.prnewswire.com\\\/rt.gif?NewsItemId=C0702&Transmission_Id=202511030800CANADANWWEB______C0702&DateId=20251103\",\"contentUrl\":\"https:\\\/\\\/rt.prnewswire.com\\\/rt.gif?NewsItemId=C0702&Transmission_Id=202511030800CANADANWWEB______C0702&DateId=20251103\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Manulife Becomes First Canadian Insurer to Offer the Galleri\u00ae Multi-Cancer Early Detection Test by GRAIL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Manulife Becomes First Canadian Insurer to Offer the Galleri\u00ae Multi-Cancer Early Detection Test by GRAIL - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/","og_locale":"en_US","og_type":"article","og_title":"Manulife Becomes First Canadian Insurer to Offer the Galleri\u00ae Multi-Cancer Early Detection Test by GRAIL - Market Newsdesk","og_description":"Canada NewsWire \u00a0Manulife helping Canadians take proactive steps for their health through access to innovative technology TORONTO , Nov. 3, 2025 \/CNW\/ – Manulife Canada today announced it is the first insurance company in Canada to offer access to GRAIL’s\u00a0Galleri\u00ae multi-cancer early detection test, to eligible life insurance customers, through its innovative Manulife Vitality program. Manulife has partnered with Medcan,\u00a0a global leader in proactive health and wellness services and the official Canadian provider of GRAIL’s\u00a0Galleri test. Through this collaboration, eligible Manulife customers will be able to access the test at Medcan’s Toronto and Oakville clinics with support from Medcan’s clinical team throughout the testing process \u2013 including pre-test counselling, results review, and next-step coordination. \u00a0 This milestone advances Manulife’s commitment … Continue reading \"Manulife Becomes First Canadian Insurer to Offer the Galleri\u00ae Multi-Cancer Early Detection Test by GRAIL\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-03T15:03:15+00:00","og_image":[{"url":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C0702&Transmission_Id=202511030800CANADANWWEB______C0702&DateId=20251103","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Manulife Becomes First Canadian Insurer to Offer the Galleri\u00ae Multi-Cancer Early Detection Test by GRAIL","datePublished":"2025-11-03T15:03:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/"},"wordCount":999,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/#primaryimage"},"thumbnailUrl":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C0702&Transmission_Id=202511030800CANADANWWEB______C0702&DateId=20251103","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/","name":"Manulife Becomes First Canadian Insurer to Offer the Galleri\u00ae Multi-Cancer Early Detection Test by GRAIL - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/#primaryimage"},"thumbnailUrl":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C0702&Transmission_Id=202511030800CANADANWWEB______C0702&DateId=20251103","datePublished":"2025-11-03T15:03:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/#primaryimage","url":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C0702&Transmission_Id=202511030800CANADANWWEB______C0702&DateId=20251103","contentUrl":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C0702&Transmission_Id=202511030800CANADANWWEB______C0702&DateId=20251103"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/manulife-becomes-first-canadian-insurer-to-offer-the-galleri-multi-cancer-early-detection-test-by-grail\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Manulife Becomes First Canadian Insurer to Offer the Galleri\u00ae Multi-Cancer Early Detection Test by GRAIL"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=904170"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904170\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=904170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=904170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=904170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}